Monoclonal Antibody Specifically Binding CD20 - Biocad Patent
Summary
The European Patent Office published Patent EP3875486A1 for a monoclonal antibody specifically binding to CD20, filed by Russian biotech company Biocad. The patent covers therapeutic applications including cancer treatments (A61P 35/00, A61P 35/02) and immune disorders (A61P 37/02). The designation extends across 38 European states including DE, FR, GB, IT, ES, NL, and others.
What changed
EPO granted Patent EP3875486A1 to Joint Stock Company Biocad for a monoclonal antibody that specifically binds to CD20. The patent application covers therapeutic uses in oncology (lymphoma, leukemia) and immunological disorders. Inventors include 19 named researchers led by Iakovev and Pestova. IPC classifications span C07K 16/28 (antibodies), C12N 5/10 (host cells), and multiple pharmaceutical applications.
Patent publication does not create immediate compliance obligations for third parties. Competitors developing CD20-targeted therapies should review the patent claims for potential freedom-to-operate concerns. Generic or biosimilar developers should assess design-around options before proceeding with R&D investments in this antibody space.
Source document (simplified)
MONOCLONAL ANTIBODY THAT SPECIFICALLY BINDS TO CD20
Publication EP3875486A1 Kind: A1 Mar 25, 2026
Applicants
Joint Stock Company "Biocad"
Inventors
IAKOVLEV, Pavel Andreevich, PESTOVA, Natalia Eugenievna, ANIKINA, Arina Vitalevna, TRUDOVISHNIKOVA, Anna Alexandrovna, SHCHEMELEVA, Mariia Aleksandrovna, KHARATIAN, Nina Grachyaevna, SOLOVYEV, Valery Vladimirovich, MISORIN, Alexey Konstantinovich, DIDUK, Sergei Vasilyevich, EROSHOVA, Anna Vladimirovna, USATOVA, Veronika Sergeevna, KRENDELEVA, Elena Andreevna, USTIUGOV, Iakov Iurevich, ALEKSANDROV, Aleksei Aleksandrovich, SMIRNOVA, Iana Andreevna, KOSKOVA, Svetlana Vladimirovna, IVANOV, Roman Alekseevich, MOROZOV, Dmitry Valentinovich
IPC Classifications
C07K 16/28 20060101AFI20220627BHEP C12N 5/10 20060101ALI20220627BHEP C12N 15/13 20060101ALI20220627BHEP C12N 15/63 20060101ALI20220627BHEP C12P 21/08 20060101ALI20220627BHEP A61K 39/395 20060101ALI20220627BHEP A61P 35/00 20060101ALI20220627BHEP A61P 35/02 20060101ALI20220627BHEP A61P 37/02 20060101ALI20220627BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Named provisions
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Pharma & Drug Safety alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ChangeBridge: EPO Bulletin - Biotech (C12N) publishes new changes.